NEA Management Company as of March 31, 2020
Portfolio Holdings for NEA Management Company
NEA Management Company holds 50 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ra Pharmaceuticals | 15.4 | $295M | 6.1M | 48.01 | |
| Oyster Point Pharma | 10.8 | $207M | 5.9M | 35.00 | |
| Sprout Social Cl A Ord (SPT) | 7.5 | $144M | 9.0M | 15.96 | |
| Allakos (ALLK) | 5.3 | $101M | 2.3M | 44.49 | |
| Network Associates Inc cl a (NET) | 5.0 | $95M | 4.1M | 23.48 | |
| Ardelyx (ARDX) | 4.8 | $92M | 16M | 5.68 | |
| Crispr Therapeutics (CRSP) | 4.6 | $89M | 2.1M | 42.41 | |
| Black Diamond Therapeutics (BDTX) | 4.5 | $86M | 3.4M | 24.95 | |
| Aurinia Pharmaceuticals (AUPH) | 3.9 | $75M | 5.2M | 14.51 | |
| Rhythm Pharmaceuticals (RYTM) | 3.9 | $75M | 4.9M | 15.22 | |
| Mersana Therapeutics (MRSN) | 3.6 | $70M | 12M | 5.83 | |
| Epizyme | 3.5 | $68M | 4.4M | 15.51 | |
| Imara | 3.4 | $64M | 4.0M | 16.03 | |
| Mirum Pharmaceuticals (MIRM) | 3.1 | $59M | 4.2M | 14.00 | |
| Adaptimmune Therapeutics (ADAP) | 2.4 | $47M | 17M | 2.72 | |
| Galera Therapeutics (GRTX) | 2.2 | $41M | 4.4M | 9.50 | |
| Casper Sleep | 1.4 | $27M | 6.2M | 4.29 | |
| Trillium Therapeutics, Inc. Cmn | 1.2 | $23M | 5.7M | 4.04 | |
| Phasebio Pharmaceuticals | 1.1 | $22M | 6.6M | 3.31 | |
| Glycomimetics (GLYC) | 1.1 | $21M | 9.1M | 2.28 | |
| Senseonics Hldgs (SENS) | 1.0 | $19M | 30M | 0.63 | |
| Trevi Therapeutics (TRVI) | 0.8 | $15M | 4.4M | 3.29 | |
| Mei Pharma | 0.7 | $14M | 8.5M | 1.61 | |
| Champions Oncology (CSBR) | 0.7 | $13M | 1.7M | 7.40 | |
| Genocea Biosciences (GNCAQ) | 0.6 | $12M | 7.2M | 1.72 | |
| Liquidia Technologies (LQDA) | 0.6 | $12M | 2.5M | 4.71 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $11M | 992k | 11.34 | |
| Obseva Sa | 0.6 | $11M | 4.6M | 2.41 | |
| Affimed Therapeutics B V | 0.5 | $9.7M | 6.1M | 1.58 | |
| Marker Therapeutics Ord | 0.5 | $9.5M | 5.0M | 1.90 | |
| Millendo Therapeutics | 0.5 | $9.3M | 1.8M | 5.28 | |
| Aveo Pharmaceuticals | 0.5 | $9.1M | 2.5M | 3.62 | |
| Strongbridge Bioph shs usd | 0.4 | $7.8M | 4.1M | 1.89 | |
| Synlogic | 0.4 | $7.3M | 4.2M | 1.72 | |
| Bloom Energy Corp (BE) | 0.4 | $7.0M | 1.3M | 5.23 | |
| Cti Biopharma | 0.3 | $6.6M | 7.1M | 0.92 | |
| Surface Oncology | 0.3 | $6.2M | 3.3M | 1.87 | |
| Rigel Pharmaceuticals | 0.3 | $5.1M | 3.2M | 1.56 | |
| Verona Pharma Plc ads (VRNA) | 0.3 | $5.0M | 1.2M | 4.12 | |
| Lexicon Pharmaceuticals (LXRX) | 0.2 | $4.6M | 2.4M | 1.95 | |
| Lumos Pharma (LUMO) | 0.2 | $4.5M | 527k | 8.50 | |
| Dasan Zhone Solutions | 0.2 | $4.0M | 956k | 4.19 | |
| Erytech Pharma Sa | 0.2 | $3.3M | 625k | 5.34 | |
| X4 Pharmaceuticals (XFOR) | 0.2 | $3.3M | 333k | 10.00 | |
| Trevena | 0.1 | $2.2M | 3.8M | 0.57 | |
| Regulus Therapeutics | 0.0 | $946k | 2.1M | 0.46 | |
| Akari Therapeutics | 0.0 | $656k | 452k | 1.45 | |
| Tracon Pharmaceuticals | 0.0 | $589k | 347k | 1.70 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $539k | 1.3M | 0.42 | |
| Endologix | 0.0 | $172k | 249k | 0.69 |
